Discover educational resources available under the QM CoE. FDA/C-Path Institute Model Informed Drug Development Web-Based Training The U.S. Food and Drug Administration’s (FDA’s) Center for Drug […]

How do I report adverse events associated with the use of a drug? FDA’s MedWatch Web site provides various means for voluntary reporting of serious postmarketing […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Terry Palmer Recipient Title CEO Matte Beauty 4495 Furking LaneDestin, FL 32541United States [email protected] Issuing Office: Center […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Karen Martin Repare Skincare 16 Spinnaker DriveMashpee, MA 02649-3654United States [email protected] Issuing Office: Center for Drug Evaluation […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Cassandra Pryor Recipient Title Manager Skin Beauty Solutions P.O. Box 25527Saint Paul, MN 55125-0527United States [email protected] Issuing […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Michelle Golde ISIS.GOLD 205 E. Butterfield Road #313Elmhurst, IL 60126United States [email protected] Issuing Office: Center for Drug […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Doug McMillon Recipient Title President and CEO Walmart, Inc. 702 SW 8th StreetBentonville, AR 72716-6299United States [email protected] […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Andy Jassy Recipient Title CEO Amazon.com, Inc. 410 Terry Ave. NSeattle, WA 98109-5210United States [email protected] Issuing Office: […]

Prescription stimulants are classified as Schedule II drugs under the Controlled Substances Act and associated with serious risks, including misuse, addiction, overdose, and diversion. Stimulants are […]